Surgery Partners, Inc. (SGRY)

NasdaqGS Currently up 0.10 (+0.72%) in today's trading session

Track congressional stock trades in Surgery Partners, Inc. (SGRY). Analyse trading activity from Nancy Pelosi and other members of Congress using public financial disclosure data.

Surgery Partners, Inc. is currently trading at $14.05, positioned at 22% of its 52-week range ($11.41 – $23.44).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$14.05
24h Change
+0.10 (+0.72%)
52 Week Range
$11.41$23.44
View on NASDAQ

Surgery Partners, Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for SGRY

Select to highlight on chart
0 transactions
Compliance: 100%
No data

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$1.84B

Volume

2.27M

Beta

1.94

P/E Ratio

36.03

Fundamentals

EPS

$0.39

Div. Yield

Open

$13.95

Day Range

$13.80 — $14.08

Company Information

Sector
Healthcare
Industry
Medical - Care Facilities
Exchange
NASDAQ · USD
Country
US
CEO
J. Eric Evans
IPO Date
2015-09-30

Surgery Partners, Inc. operates a nationwide network of surgical facilities and associated medical services across the United States. Its business is categorized into two segments: Surgical Facility Services and Ancillary Services. These surgical ven...

Earnings

Next Report

Q3 2026

9 Nov

EPS Est.

$0.09

Rev. Est.

$854.8M

Days Until

75

Recent Quarters

Q2 202610 Aug
EPS$0.10
Beat 72.6%
Q1 20265 May
EPS$-0.03
Beat 80.0%
Q4 20252 Mar
EPS$0.12
Miss 61.3%
Q3 202510 Nov
EPS$0.13
Miss 31.6%
Q2 20255 Aug
EPS$0.17
Beat 6.3%
Q1 202512 May
EPS$0.04
Miss 50.0%
Q4 20243 Mar
EPS$0.44
Beat 15.8%
Q3 202412 Nov
EPS$0.19
Miss 24.0%
Q2 20246 Aug
EPS$0.21
Beat 0.0%
Q1 20247 May
EPS$0.10
Beat 42.9%
Q4 202326 Feb
EPS$0.44
Beat 18.9%
Q3 20237 Nov
EPS$0.19
Beat 35.7%
Q2 20231 Aug
EPS$0.28
Beat 300.0%
Q1 20231 May
EPS$0.08
Beat 1951.3%
Q4 20221 Mar
EPS$0.27
Beat 42.1%
Q3 20228 Nov
EPS$-0.02
Miss 143.9%
Q2 20222 Aug
EPS$-0.03
Miss 344.4%
Q1 20223 May
EPS$-0.09
Miss 80.0%
Q4 202128 Feb
EPS$0.23
Miss 11.5%
Q3 20212 Nov
EPS$-0.05
Miss 52.1%
Q2 20214 Aug
EPS$-0.39
Miss 76.5%
Q1 20215 May
EPS$-0.30
Miss 20.0%
Q4 202010 Mar
EPS$0.09
Miss 30.8%
Q3 20204 Nov
EPS$-0.53
Miss 76.7%
Q2 20205 Aug
EPS$-0.48
Beat 5.9%
Q1 202011 May
EPS$-0.34
Beat 41.4%
Q4 20195 Mar
EPS$0.10
Miss 16.7%
Q3 20195 Nov
EPS$-0.28
Beat 0.0%
Q2 20197 Aug
EPS$-0.29
Miss 70.6%
Q1 20198 May
EPS$-0.42
Miss 40.0%
Q4 201813 Mar
EPS$-0.74
Miss 511.1%
Q3 20187 Nov
EPS$-0.19
Miss 111.1%
Q2 20189 Aug
EPS$-0.18
Miss 20.0%
Q1 20189 May
EPS$-0.26
Miss 36.8%
Q4 20171 Mar
EPS$-0.03
Miss 906.7%
Q3 20178 Nov
EPS$-0.02
Beat 77.8%
Q2 20178 Aug
EPS$-0.01
Miss 105.6%
Q1 20179 May
EPS$0.04
Miss 42.9%
Q4 20169 Mar
EPS$0.19
Miss 5.0%
Q3 20169 Nov
EPS$0.21
Beat 50.0%
Q2 20169 Aug
EPS$0.16
Beat 14.3%
Q1 20165 May
EPS$-0.15
Miss 400.0%
Q4 201510 Mar
EPS$0.47
Beat 147.4%
Q3 201512 Nov
EPS$0.04
Beat 300.0%
Q3 20151 Oct
EPS$-0.11
Q4 201431 Mar
EPS$-0.14
Q2 201430 Sept
EPS$-0.14

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.